Nov 30, 2016 10:15 AM IST | Source: CNBC-TV18

Stocks in news: Tata Power, Lupin, Vivimed, Bharat Forge, Idea

Idea Cellular | Lupin | Tata Power | Bharat Forge | Oil India | National Fertilizers | Wanbury | Vivimed Labs | Ramco Cements | Sarda Energy | HCC | Indian Hotels | Eros International and SAIL are stocks, which are in the news today.

Here are stocks that are in news today:

Results today: Punj Lloyd, GVK Power, Gujarat State Petronet, Balkrishna Industries, Graphic Charts, Man Infra, Ratnamani Metal, Tentiwala Metal

Tata Power Q2
-Net profit at Rs 336.2 crore versus loss of Rs 95.9 crore (YoY)
-Total income down 6 percent at Rs 7,208.9 crore versus Rs 7,666.3 crore (YoY)
-EBITDA down 27.2 percent at Rs 1,461.6 crore versus Rs 2,008 crore (YoY)
-EBITDA margin at 20.3 percent versus 26.2 percent (YoY)
-Regulatory expense at Rs 306.4 crore versus Rs 495.3 crore (YoY)
Tata Power says
-Paid Rs 790 crore to Tata Sons as share in DoCoMo case
-Recognised loss of Rs 124.5 crore on reassessing fair value of TTSL

National Fertilizers Q2
-Net profit down 10.7 percent at Rs 46.5 crore versus Rs 52.1 crore (YoY)
-Total income down 15.9 percent at Rs 1,901.9 crore versus Rs 2,260.4 crore (YoY)
-EBITDA down 11.7 percent at Rs 139.2 crore versus Rs 157.6 crore (YoY)
-EBITDA margin at 7.3 percent versus 7 percent (YoY)

Wanbury Q2
-Net profit at Rs 7.1 crore versus loss of Rs 2.4 crore (YoY)
-Total income up 14.6 percent at Rs 122.1 crore versus Rs 106.5 crore (YoY)
-EBITDA margin at 9.9 percent versus 8.7 percent (YoY)
-Other income at Rs 1.7 crore versus Rs 0.2 crore (YoY)
-Finance cost at Rs 4.4 crore versus Rs 9.8 crore (YoY)

Tamil Nadu Newsprint and Papers Q2
-Net profit up 18.7 percent at Rs 70.6 crore versus Rs 59.5 crore (YoY)
-Total income up 22.15 at Rs 709.4 crore versus Rs 581 crore (YoY)
-EBITDA up 27.7 percent at Rs 176.4 crore versus Rs 138.1 crore (YoY)
-EBITDA margin at 24.9 percent versus 23.8 percent (YoY)

Other stocks and sectors that are in news today:
-Tata Power says stake sale consideration for PT Arutmin revised to USD 246.6 million from USD 390 million
-Torrent Pharma gets US FDA nod for Amlodipine & Olmesartan Medoxomil tablets (used to treat hypertension)
-Indo Amines - CARE suspends existing ratings; CRISIL assigns long term rating of BBB+ and short term rating of A2
-JK Paper - India Ratings & Research assigns A- to term deposits
-Capri Global - CARE reaffirms long term rating of A+
-Lupin gets FDA approval for generic Nuvigil tablets
-Centum Electronics' proposal to increase stake in Adetel Group from 51 percent to 54.1 percent
-Vivimed Labs says successful USFDA inspection of FDF facility in Alathur
-Government of India approves SAIL's strategic divestment of Bhadrawati, Salem and Durgapur units
-UCO Bank issued and allotted 7.17 crore shares at Rs 37.74 per share
-Ramco Cements - The Competition Appellate Tribunal stays penalty amount of Rs 258.53 crore imposed by Competition Commission of India, orders to deposit 10 percent of penalty amount within 1 month
-State Bank of Bikaner and Jaipur revises MCLR (marginal cost of funds based lending rate) across all tenors from 8.75 percent to 9.3 percent
-Sarda Energy says operations restored at iron ore mine
-HCC board meeting on December 2 to consider issue of equity and OCDs (optionally convertible debentures) on preferential basis to lenders
-Eros International board meeting on December 2 to consider issue of non-convertible debentures (NCDs)
-Oil India approved winding up of subsidiary – Oil India International
-Axiata may sell 20 percent stake in Idea Cellular: ET
-Tata Group in focus - Noel Tata in race for chairman’s position in Tata Sons: ET
-Indian Hotels in focus - Taj ties up with Shangrila in bid to expand global foot print
-Sundaram Trading launches book to sell Bharat Forge shares of up to USD 30 million: Sources
-SBI sets overnight MCLR rate at 8.65 percent from December 1

Sections
Follow us on
Available On